Literature DB >> 16856307

The sham ECT literature: implications for consent to ECT.

Colin A Ross1.   

Abstract

The author reviewed the placebo-controlled literature on electroconvulsive therapy (ECT) for depression. No study demonstrated a significant difference between real and placebo (sham) ECT at 1 month posttreatment. Many studies failed to find a difference between real and sham ECT even during the period of treatment. Claims in textbooks and review articles that ECT is effective are not consistent with the published data. A large, properly designed study of real versus sham ECT should be undertaken. In the absence of such a study, consent forms for ECT should include statements that there is no controlled evidence demonstrating any benefit from ECT at 1 month posttreatment. Consent forms should also state that real ECT is only marginally more effective than placebo.

Entities:  

Keywords:  Empirical Approach; Mental Health Therapies

Mesh:

Substances:

Year:  2006        PMID: 16856307     DOI: 10.1891/ehpp.8.1.17

Source DB:  PubMed          Journal:  Ethical Hum Psychol Psychiatry        ISSN: 1559-4343


  4 in total

Review 1.  Placebo eff ects in psychiatry: mediators and moderators.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Lancet Psychiatry       Date:  2015-03       Impact factor: 27.083

2.  Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials.

Authors:  Kaitlin R McManus; Maria I Lapid; Brent P Forester; Martina Mueller; Adriana P Hermida; Louis Nykamp; David G Harper; Stephen J Seiner; Sohag Sanghani; Regan Patrick; Melanie T Gentry; Simon Kung; Janette C Leal; Emily K Johnson; Georgios Petrides
Journal:  J ECT       Date:  2022-03-01       Impact factor: 3.692

3.  A response to yet another defence of ECT in the absence of robust efficacy and safety evidence.

Authors:  John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2022-02-15       Impact factor: 6.892

4.  Electroconvulsive Treatment: Hypotheses about Mechanisms of Action.

Authors:  Roar Fosse; John Read
Journal:  Front Psychiatry       Date:  2013-08-27       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.